Acurx Pharmaceuticals, Inc. (ACXP)
2.84
-0.09
(-3.07%)
USD |
NASDAQ |
Apr 14, 16:00
2.74
-0.10
(-3.52%)
After-Hours: 17:37
Acurx Pharmaceuticals Cash from Investing (TTM) : 0.00 for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Apyx Medical Corp. | -1.054M |
| Quince Therapeutics, Inc. | 23.23M |
| Lantern Pharma, Inc. | 11.06M |
| Sensei Biotherapeutics, Inc. | 14.54M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |